GRF6019
- Generic Name
- GRF6019
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Alkahest, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT03765762
- Locations
- 🇺🇸
Cognitive Clinical Trials, Phoenix, Arizona, United States
🇺🇸Pacific Research Network, San Diego, California, United States
🇺🇸Riverside Clinical Research, Edgewater, Florida, United States
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2
Completed
- Conditions
- Mild to Moderate Alzheimer DiseaseAlzheimer Disease
- Interventions
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Alkahest, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT03520998
- Locations
- 🇺🇸
Princeton Medical Institute, Princeton, New Jersey, United States
🇺🇸CNS Network, Long Beach, California, United States
🇺🇸Synergy East, Lemon Grove, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath